JARSIX 5/0.25MG 10 TAB CLONIXINATO DE LISINA PRINCIPIO ACTIVO: CANAGLIFLOZINA

Description

PRINCIPIO ACTIVO: CANAGLIFLOZINA

Baricitinib 2 mg

FORMA FARMACÉUTICA: 21 TABLETAS

La dosis debe ajustarse individualmente con base en niveles de glucosa

Laboratorio:NOVO NORDISK

JARSIX 5/0.25MG 10 TAB CLONIXINATO DE LISINA PRINCIPIO ACTIVO: CANAGLIFLOZINAPRINCIPIO ACTIVO: LORATADINA, BETAMETASONA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy